---
title: Brazil’s ANVISA to Recognize Selected Overseas Approvals
description: ANVISA Streamlining MD and IVD Product Registration
image: https://blog.arazygroup.com/hubfs/Brazil-1.jpg
---

Open main menu Close main menu

- [Join The Regulatory Rockstar Movement](https://info.arazygroup.com/regulatory_rockstar_movement)

[Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

# Brazil’s ANVISA to Recognize Selected Overseas Approvals

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.arazygroup.com/regulatory-affairs-advance/brazils-anvisa-to-recognize-selected-overseas-approvals) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.arazygroup.com/regulatory-affairs-advance/brazils-anvisa-to-recognize-selected-overseas-approvals) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.arazygroup.com/regulatory-affairs-advance/brazils-anvisa-to-recognize-selected-overseas-approvals)

![](https://blog.arazygroup.com/hubfs/Brazil-1.jpg)

Brazil's Draft Resolution 1200, dated September 1st, 2023, outlining a streamlined process for evaluating and deciding on medical device and IVD registration requests using analyses conducted by an Equivalent Foreign Regulatory Authority, has been adopted as Normative Instruction 290. It was adopted on April 4th, 2024, and will be effective from June 4th, 2024.

The option allowing ANVISA to leverage registrations from overseas regulators for identical devices when the regulator is considered equivalent to ANVISA is only available to class III and IV devices.

The market authorizations/certifications from overseas regulators, specifically the other Full Members of the MDSAP program, with whom Brazil has confidentiality agreements for information exchange, are included within the scope:

1. **Australia:** TGA, Australian Register of Therapeutic Goods
2. **Canada:** Health Canada, Medical Device Licence
3. **USA:** FDA, 510(k) Clearance, Premarket Approval, 513(f)(2) “De Novo”
4. **Japan:** Ministry of Health, Labour and Welfare, Pre-market approval

In recent months, MedTech Europe has actively participated in dialogues with both ANVISA and the European Commission (specifically DG SANTE) to advocate for the inclusion of MDR and IVDR devices within the scope of a particular policy. ANVISA has communicated that EU approvals may be incorporated following the conclusion of the extended transition periods outlined in the amendment to EU MDR and IVDR regulations. Recognizing this potential, as Europe progresses through its transition periods, MedTech Europe remains committed to pursuing opportunities to foster engagement and integrate the EU framework into Brazil’s reliance pathway.

The final text (in Portuguese) is [available here](https://antigo.anvisa.gov.br/documents/10181/6649665/IN_290_2024_.pdf/e5960d9a-d41f-4fef-bc7a-12e9aedbd28e).

## Related Articles

[![](https://blog.arazygroup.com/hubfs/Brazil.jpg)](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil-1)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

### [Regulatory Update: Brazil](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil-1)

In Brazil, a significant regulatory development in the realm of healthcare emerged with the issuance of Resolution RDC No. 830 by the National Health Surveillance Agency...

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil-1)

[![](https://blog.arazygroup.com/hubfs/imgpsh_fullsize_anim-Nov-06-2023-11-01-11-6389-PM.jpg)](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil)

[Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

### [Regulatory Update: Brazil](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil)

On August 17, 2023, the National Health Surveillance Agency in Brazil (ANVISA) published the Resolution - RDC No. 810 for risk classification, notification, registration...

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-brazil)

[Follow us on Facebook](https://www.facebook.com/Arazygroup/) [Follow us on LinkedIn](https://www.linkedin.com/company/arazy-group) [Follow us on Instagram](https://www.instagram.com/arazy_group/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Arazy Group",
    "url" : "https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group"
  },
  "dateModified" : "2024-06-21T18:35:10.090Z",
  "datePublished" : "2024-04-18T20:36:45.000Z",
  "headline" : "Brazil’s ANVISA to Recognize Selected Overseas Approvals",
  "image" : [ "https://blog.arazygroup.com/hubfs/Brazil-1.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.arazygroup.com/regulatory-affairs-advance/brazils-anvisa-to-recognize-selected-overseas-approvals",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.arazygroup.com/hubfs/Arazy%20Group%20Logos%201.png"
    },
    "name" : "Arazy Group Consultants Inc."
  }
}
```